Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The 22q11.2 deletion syndrome.

Hiroyuki Yamagishi1

  • 1Department of Pediatrics and Molecular Biology, University of Texas Southwestern Medical Center, Dallas 75390-9148, USA. hyamag@mednet.swmed.edu

The Keio Journal of Medicine
|July 20, 2002
PubMed
Summary

22q11.2 deletion syndrome (22q11DS) is a common genetic disorder affecting pharyngeal arch development. Understanding its variable clinical features and molecular basis is crucial for patient management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same author

Registry-based estimation of cardiac event-free survival in congenital heart disease complicated by pulmonary hypertension: A nationwide registry study from Japan.

International journal of cardiology. Congenital heart disease·2026
Same author

Mid-term prognosis and risk stratification in patients with post-operative pulmonary hypertension: Insights from the Japanese Association of Congenital Heart Disease Registry (JACPHR).

American heart journal plus : cardiology research and practice·2026
Same author

Systematic Review of the Application of Pulmonary Hypertension Treatments in Ventricular Septal Defect, Pulmonary Atresia, and Major Aortopulmonary Collateral Arteries.

Journal of clinical medicine·2026
Same author

Maternal Folic Acid Supplementation Ameliorates Outflow Tract Malformations in Tbx1 Hypomorphic Mice via Notch and Midkine Signaling.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same author

Long-term effectiveness and safety of daily growth hormone therapy in Japanese children with Noonan syndrome: a post-marketing surveillance study.

Endocrine journal·2025

Area of Science:

  • Genetics
  • Developmental Biology
  • Clinical Medicine

Background:

  • 22q11.2 deletion syndrome (22q11DS) is the most frequent interstitial deletion in humans, affecting 1 in 4,000 live births.
  • It encompasses DiGeorge, velo-cardio-facial, and conotruncal anomaly face syndromes, characterized by diverse clinical findings.
  • The syndrome's significant phenotypic variability and lack of clear genotype-phenotype correlations present diagnostic and management challenges.

Purpose of the Study:

  • To review the clinical features and management strategies for 22q11DS.
  • To integrate current understanding of the embryological and molecular basis of 22q11DS.
  • To highlight the role of haploinsufficiency in pharyngeal arch and pouch development.

Main Methods:

  • Review of clinical findings and management protocols for 22q11DS patients.
  • Analysis of embryological development, focusing on pharyngeal arch and pouch derivatives.
  • Integration of molecular genetics data, including gene identification in the deleted region.
  • Consideration of insights from experimental animal models and genome manipulation technologies.

Main Results:

  • 22q11DS involves a microdeletion on chromosome 22q11.2, impacting development of structures derived from pharyngeal arches and pouches.
  • Over 30 genes are located within the deleted region, though their specific roles in the syndrome are still being elucidated.
  • Experimental models, particularly in mice, are providing insights into the developmental roles of genes like TBX1.

Conclusions:

  • Comprehensive evaluation and follow-up are essential for managing the wide spectrum of 22q11DS clinical manifestations.
  • Haploinsufficiency of genes within the 22q11.2 region is critical for normal pharyngeal arch/pouch development.
  • Further research, including advanced genetic and developmental studies, is needed to fully understand the molecular basis and variability of 22q11DS.

Related Experiment Videos